FAQs & How to use this site
Home | About Us | Contact Us
The Front Line
The Front Line: Charles D. Blanke, MD, SWOG Chair
ABOUT

PREVIOUS POSTS October 2017

September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 JUNE 2016 MAY 2016 APRIL 2016 MARCH 2016 FEB 2016 JAN 2016 DEC 2015 NOV 2015 OCT 2015 SEP 2015 AUG 2015 JUL 2015 JUN 2015 MAY 2015 APR 2015 MAR 2015 FEB 2015 JAN 2015 DEC 2014 NOV 2014 OCT 2014 SEP 2014 AUG 2014 JUL 2014 JUN 2014 MAY 2014 APR 2014 MAR 2014 FEB 2014 JAN 2014 DEC 2013 NOV 2013 OCT 2013 SEP 2013 AUG 2013 JUL 2013

SWOG's Innovation Working Group

Aug 30, 2013 - One of the most exciting initiatives SWOG has launched this year is our Innovation Working Group (IWG). The idea isn't new; many medical and non-medical organizations alike have dedicated teams working to develop novel ideas and strategies.

SWOG's IWG is led by our Vice-Chair for Translational Medicine Lee Ellis, who founded and has successfully led the NCI GI Cancer Steering Committee's IWG. Our IWG also numbers among its members key leaders from our basic science cancer center partners Cold Spring Harbor Laboratory (CSHL) and The Jackson Laboratory (JAX).

Our IWG's specific charges include the following:

  • Regularly review the trial portfolio of each research committee to ensure it has a balance of studies that incorporate biomarker and other translational objectives with the potential to drive significant clinical advances. This review cycle will start at the Spring 2014 group meeting in San Francisco.

  • Make recommendations for preclinical studies that will inform upcoming clinical trials.

  • Regularly review the SWOG Biorepository inventory, to identify opportunities for research that could have a major impact on the development of future clinical trials.

  • Scout out key translational medicine articles in journals not typically subscribed to by clinical researchers, sharing most relevant ones with SWOG investigators. These are distributed via the Friday "link of the week" mailings that go from Drs. Ellis and Rae to all our investigators.

  • Develop the agenda for the Plenary Part I Translational Medicine session held on Thursdays at our live semi-annual group meetings.

  • Help develop "cross-training" workshops that bring together clinical and laboratory scientists to educate each other on the work done by each group.

  • Supervise the review of proposals for HOPE Foundation Developmental Award funding.

Here is more information on just one of the most exciting ideas to come out of our IWG: Live "office hours" will be held by lab scientists, giving clinical investigators a chance to meet with them to discuss possible collaborations. Five scientists will hold office hours Friday, October 11, at the Chicago meeting. Sign up for a specific time slot.

I hope you agree the IWG efforts will markedly enhance our translational efforts and help us achieve our primary mission: making a difference in the lives of patients with cancer.

 

 
     
SWOG Logo Disclaimer | Copyright ©2000-2017 SWOG. All rights reserved.
Design by nuMedia Group Inc. | Hosting by WorldPost Technologies, Inc.
SWOG is FISMA CertifiedSWOG is FISMA Certified